Anti-HCV antibody presence in hemodialyzed patients: assessment after one year regarding some preventive measures chosen.
The authors report on the presence of anti-HCV antibodies in a uremic chronic (UC) patient population after 6 months and 1 year with regard to certain selective preventive measures. The nonincreased number of HCV-positive subjects among the UC population could lead to the conclusion that the risk of environmental spreading of HCV is less than the risk of HBV diffusion.
Di Benedetto
A
A
Sezione di Nefrologia ed Emodialisi, Ospedale dei Pellegrini, USL 44, Napoli, Italia.
Bilotta
E
E
Minale
S
S
Tritto
M C
MC
Russo Spena
S
S
Picardi
E
E
Sorice
P
P
D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D006435:Renal Dialysis / Q000009:adverse effects*; D013997:Time Factors; D014511:Uremia / Q000628:therapy
D006508:Hepatitis Antibodies